These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29045770)

  • 1. Treatment to Enhance Cognition in Bipolar Disorder (TREC-BD): Efficacy of a Randomized Controlled Trial of Cognitive Remediation Versus Active Control.
    Lewandowski KE; Sperry SH; Cohen BM; Norris LA; Fitzmaurice GM; Ongur D; Keshavan MS
    J Clin Psychiatry; 2017; 78(9):e1242-e1249. PubMed ID: 29045770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive remediation versus active computer control in bipolar disorder with psychosis: study protocol for a randomized controlled trial.
    Lewandowski KE; Sperry SH; Ongur D; Cohen BM; Norris LA; Keshavan MS
    Trials; 2016 Mar; 17(1):136. PubMed ID: 26969299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analytic investigation of cognitive remediation for mood disorders: Efficacy and the role of study quality, sample and treatment factors.
    Goldberg Z; Kuslak B; Kurtz MM
    J Affect Disord; 2023 Jun; 330():74-82. PubMed ID: 36868388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Remediation in Bipolar (CRiB2): study protocol for a randomised controlled trial assessing efficacy and mechanisms of cognitive remediation therapy compared to treatment as usual.
    Tsapekos D; Strawbridge R; Cella M; Goldsmith K; Kalfas M; Taylor RH; Swidzinski S; Marwaha S; Grey L; Newton E; Shackleton J; Harrison PJ; Browning M; Harmer C; Hartland H; Cousins D; Barton S; Wykes T; Young AH
    BMC Psychiatry; 2023 Nov; 23(1):842. PubMed ID: 37968619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial.
    Ott CV; Vinberg M; Bowie CR; Christensen EM; Knudsen GM; Kessing LV; Miskowiak KW
    Trials; 2018 Sep; 19(1):487. PubMed ID: 30208971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Action-Based Cognitive Remediation on cognitive impairment in patients with remitted bipolar disorder: A randomized controlled trial.
    Ott CV; Vinberg M; Kessing LV; Bowie CR; Forman JL; Miskowiak KW
    Bipolar Disord; 2021 Aug; 23(5):487-499. PubMed ID: 33053258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Short-Term Cognitive Remediation on Cognitive Dysfunction in Partially or Fully Remitted Individuals with Bipolar Disorder: Results of a Randomised Controlled Trial.
    Demant KM; Vinberg M; Kessing LV; Miskowiak KW
    PLoS One; 2015; 10(6):e0127955. PubMed ID: 26070195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of cognitive remediation on cognitive abilities and real-world functioning among people with bipolar disorder: A systematic review: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
    Bellani M; Biagianti B; Zovetti N; Rossetti MG; Bressi C; Perlini C; Brambilla P
    J Affect Disord; 2019 Oct; 257():691-697. PubMed ID: 31377606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does cognitive improvement translate into functional changes? Exploring the transfer mechanisms of cognitive remediation therapy for euthymic people with bipolar disorder.
    Tsapekos D; Strawbridge R; Cella M; Young AH; Wykes T
    Psychol Med; 2023 Feb; 53(3):936-944. PubMed ID: 34140055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive and Self-efficacy Benefits of Cognitive Remediation in Schizophrenia: A Randomized Controlled Trial.
    Bryce SD; Rossell SL; Lee SJ; Lawrence RJ; Tan EJ; Carruthers SP; Ponsford JL
    J Int Neuropsychol Soc; 2018 Jul; 24(6):549-562. PubMed ID: 29352823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial examining a cognitive behavioral therapy intervention enhanced with cognitive remediation to improve work and neurocognition outcomes among persons with schizophrenia spectrum disorders.
    Kukla M; Bell MD; Lysaker PH
    Schizophr Res; 2018 Jul; 197():400-406. PubMed ID: 29422299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards a biomarker model for cognitive improvement: No change in memory-related prefrontal engagement following a negative cognitive remediation trial in bipolar disorder.
    Macoveanu J; Demant KM; Vinberg M; Siebner HR; Kessing LV; Miskowiak KW
    J Psychopharmacol; 2018 Oct; 32(10):1075-1085. PubMed ID: 29969938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive remediation for the treatment of neuropsychological disturbances in subjects with euthymic bipolar disorder: findings from a controlled study.
    Bernabei L; Bersani FS; Pompili E; Delle Chiaie R; Valente D; Corrado A; Vergnani L; Ferracuti S; Biondi M; Coccanari de'Fornari MA
    J Affect Disord; 2020 Aug; 273():576-585. PubMed ID: 32560956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial.
    Miskowiak KW; Ehrenreich H; Christensen EM; Kessing LV; Vinberg M
    J Clin Psychiatry; 2014 Dec; 75(12):1347-55. PubMed ID: 25099079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive remediation therapy for patients with bipolar disorder: A randomised proof-of-concept trial.
    Strawbridge R; Tsapekos D; Hodsoll J; Mantingh T; Yalin N; McCrone P; Boadu J; Macritchie K; Cella M; Reeder C; Fish J; Wykes T; Young AH
    Bipolar Disord; 2021 Mar; 23(2):196-208. PubMed ID: 32583630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trial of Interpersonal and Social Rhythm Therapy and group-based Cognitive Remediation versus Interpersonal and Social Rhythm Therapy alone for mood disorders: study protocol.
    Douglas KM; Inder ML; Crowe MT; Jordan J; Carlye D; Lacey C; Beaglehole B; Mulder R; Eggleston K; Donovan KA; Frampton CMA; Bowie CR; Porter RJ
    BMC Psychiatry; 2022 Feb; 22(1):115. PubMed ID: 35164720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using visual processing training to enhance standard cognitive remediation outcomes in schizophrenia: A pilot study.
    Contreras NA; Tan EJ; Lee SJ; Castle DJ; Rossell SL
    Psychiatry Res; 2018 Apr; 262():494-499. PubMed ID: 28967441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.
    Petersen JZ; Schmidt LS; Vinberg M; Jørgensen MB; Hageman I; Ehrenreich H; Knudsen GM; Kessing LV; Miskowiak KW
    Trials; 2018 Nov; 19(1):611. PubMed ID: 30400939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive remediation for people with bipolar disorder: The contribution of session attendance and therapy components to cognitive and functional outcomes.
    Tsapekos D; Strawbridge R; Wykes T; Young AH; Cella M
    J Psychiatr Res; 2022 Aug; 152():144-151. PubMed ID: 35724496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Training for Schizotypal Personality Disorder.
    McClure MM; Graff F; Triebwasser J; Perez-Rodriguez M; Rosell DR; Koenigsberg H; Hazlett EA; Siever LJ; Harvey PD; New AS
    Am J Psychiatry; 2019 Apr; 176(4):307-314. PubMed ID: 30654644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.